A study looking at blood levels of chemotherapy drugs in people with Ewing's sarcoma (PK 2013 01)

Cancer type:

Children's cancers
Ewing's sarcoma





This study is looking at what happens to chemotherapy drugs in the body during treatment for Ewing’s sarcoma. The study is supported by Cancer Research UK.

This study is for both adults and children. We use the term ‘you’ in this summary, but of course if you are a parent, we are referring to your child.

Treatment for Ewing’s sarcoma usually includes chemotherapy. You may have treatment that includes the drugs vincristine, ifosfamide, doxorubicin and etoposide. Doctors call this VIDE.

Or you may have vincristine, doxorubicin, cyclophosphamide, ifosfamide and etoposide, which is called VDC/IE.

We know from research that there are variations in how people get rid of these drugs from their bodies. In this study, researchers are measuring levels of the drugs in the blood after treatment. It is called a pharmacokinetic Open a glossary item study.

The main aims of the study are to see

  • If the blood levels influence the side effects people have and their response to the drugs
  • How the blood levels vary in people of different ages

Taking part in this study will not affect the treatment you have. The results may improve the way doctors use these chemotherapy drugs in the future.

Who can enter

You may be able to enter this study if you

  • Have Ewing’s sarcoma and are having either VIDE or VDC/IE chemotherapy as part of your treatment
  • Have had a tube put into your chest to give drugs directly into one of your major blood vessels (a central line)

You cannot enter the study if

  • You are having another type of chemotherapy that is not standard treatment Open a glossary item
  • The doctors running the study don’t think it would be right for you to take part

Trial design

The study will recruit 120 people having chemotherapy for Ewing’s sarcoma.

You have chemotherapy in cycles of treatment. If you take part in this study, the study team will take a number of blood samples during 1 cycle of your chemotherapy treatment.

They will take the first blood sample before you start a cycle of chemotherapy. They then take up to 8 more samples over the next 4 days. They will take the blood from your central line so you won’t need to have any extra needles.

They study team will also take extra samples to study certain genes that may control how fast the drugs are removed from your body and to see if they can predict which patients may be more likely to have side effects. They will take these samples before you start your 1st and 3rd cycles of chemotherapy and when you finish your first type of chemotherapy. The researchers want to see if they can work out at an early stage in treatment who is likely to get infections or a sore mouth because of the chemotherapy.

Hospital visits

Taking part in the study doesn’t involve any extra hospital visits.

Side effects

There are no side effects from taking part in this study.


Newcastle upon Tyne

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Quentin Campbell Hewson

Supported by

Cancer Research UK
The Newcastle upon Tyne Hospitals NHS Foundation Trust
University of Newcastle

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:


Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Wendy took part in a new trial studying the possible side effect of hearing loss

A picture of Wendy

"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page